Komori
Perseus Proteomics (4882) · InitiativeRestated

Transition to a Company with an Audit and Supervisory Committee and Strengthening Oversight by Outside Directors

First written in FY2021. 3 of 4 entries say "Restated". Latest entry: FY2025.

4entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20252021: 120212022: 120222023: 120232024: 020242025: 12025
Same theme, other companies
Transition to a Company with an Audit and Supervisory CommitteeA theme 774 companies write about · 0 as a headwind · 783 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 783 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「The company's Audit and Supervisory Committee currently comprises 3 members, all of whom are outside directors. Following the transition to a company with an Audit and Supervisory Committee, directors who are Audit and Supervisory Committee members have voting rights at Board of Directors meetings in addition to conducting audits, which the company believes ensures an effective oversight function over management and the directors.」

    The company-with-an-audit-and-supervisory-committee structure and oversight by 3 outside directors were reaffirmed.
  2. FY2023RestatedAnnual report

    「The company's Audit and Supervisory Committee currently comprises 3 members, all of whom are outside directors. Following the transition to a company with an Audit and Supervisory Committee, directors who are Audit and Supervisory Committee members have voting rights at Board of Directors meetings in addition to conducting audits, which the company believes ensures an effective oversight function over management and the directors.」

    The company continues to operate an oversight framework comprising a company with an Audit and Supervisory Committee and 3 outside directors.
  3. FY2022RestatedAnnual report

    「To ensure management efficiency and soundness and further strengthen corporate governance, the company transitioned, based on a resolution of the annual general meeting of shareholders held on 29 June 2020, to a company with an Audit and Supervisory Committee consisting of at least 3 directors, including highly independent outside directors.」

    The company continues to operate an oversight framework comprising a company with an Audit and Supervisory Committee and outside directors.
  4. FY2021First statedAnnual report

    「To ensure management efficiency and soundness and further strengthen corporate governance, the company transitioned, based on a resolution of the annual general meeting of shareholders held on 29 June 2020, to a company with an Audit and Supervisory Committee consisting of at least 3 directors, including highly independent outside directors.」

    The company changed from a company with a Board of Corporate Auditors to a company with an Audit and Supervisory Committee, adopting a framework under which Audit and Supervisory Committee members have voting rights at Board of Directors meetings.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Perseus Proteomics yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Transition to a Company with an Audit and Supervisory Committee and Strengthening Oversight by Outside Directors | Perseus Proteomics Inc. (4882) | Komori